T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie Ewer(University of Oxford), Megan Baker, Maheshi Ramasamy(University of Oxford), Mustapha Bittaye(University of Oxford), Yama F Mujadidi(University of Oxford), Brian Angus(University of Oxford), Hannah Sharpe(University of Oxford), Marion Watson(University of Oxford), Eleanor Berrie(University of Oxford), Nicholas M. Provine(University of Oxford), Duncan Bellamy(University of Oxford), Paola Cicconi(University of Oxford), Jordan R. Barrett(National Institute for Health and Care Research), Richard Tarrant(University of Oxford), Matthew D. Snape(University of Oxford), Elizabeth Clutterbuck(University of Oxford), Irina Chelysheva(University of Oxford), Jamie Fowler(University of Oxford), Adrian V. S. Hill(Jenner Institute), Alison M. Lawrie(University of Oxford), Parvinder K. Aley(University of Oxford), Christina Dold(University of Oxford), Ian Poulton(University of Oxford), Michelle Fuskova(University of Oxford), Richard Morter(University of Oxford), Catherine Green(University of Oxford), Daniel Jenkin(University of Oxford), Daniel Wright(University of Oxford), Rebecca Makinson(University of Oxford), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Angela M. Minassian(National Institute for Health and Care Research), Sarah E. Silk(University of Oxford), Alexander D. Douglas(University of Oxford), Pedro M. Folegatti(University of Oxford), Jennifer Alderson(University of Oxford), Andrew J. Pollard(University of Oxford), Simon Kerridge(University of Oxford), Sagida Bibi(University of Oxford), Elizabeth Allen, Sandra Belij‐Rammerstorfer(University of Oxford), Amy Flaxman(University of Oxford), Maria Moore(University of Oxford), Hannah Robinson(University of Oxford), Emma Plested(University of Oxford), Jeremy Aboagye, Aabidah Ali, Rinn Song(University of Oxford), Merryn Voysey(Stratasys (Israel)), Teresa Lambe(Science Oxford)
Cited by 643
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k